Cobicistat : A case of mislabelled drug-drug interaction risk?

Burger, David M; Calmy, Alexandra; Marzolini, Catia

doi:10.1111/bcp.14262

Scientific article

Editorial

English

Cobicistat : A case of mislabelled drug-drug interaction risk?

ContributorsBurger, David M

; Calmy, Alexandra

; Marzolini, Catia

Published inBritish journal of clinical pharmacology, vol. 86, no. 5, p. 834-836

Publication date2020-05

First online date2020-03-06

Keywords

HIV/AIDS
Cytochrome P450
Drug interactions
Anti-HIV Agents / pharmacology
Cobicistat / pharmacology
Darunavir
Drug Interactions
Drug Labeling
HIV Infections / drug therapy
Humans
Pharmaceutical Preparations

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

BURGER, David M, CALMY, Alexandra, MARZOLINI, Catia. Cobicistat : A case of mislabelled drug-drug interaction risk? In: British journal of clinical pharmacology, 2020, vol. 86, n° 5, p. 834–836. doi: 10.1111/bcp.14262

Article (Published version)

CC BY-NC-4.0

Identifiers

PID : unige:173261
DOI : 10.1111/bcp.14262
PMID : 32144787
PMCID : PMC7163374

Journal ISSN0306-5251

52views

11downloads

Creation23/02/2022 14:41:01

First validation22/11/2023 14:52:15

Update time22/11/2023 14:52:15

Status update22/11/2023 14:52:15

Last indexation01/11/2024 06:48:31

Archive ouverte UNIGE

Cobicistat : A case of mislabelled drug-drug interaction risk?

Technical informations